Conditioning with fludarabine and targeted busulfan before transplantation of allogeneic hematopoietic stem cells.

被引:0
|
作者
Bornhaeuser, M
Storer, B
Slattery, JT
Appelbaum, FR
Deeg, HJ
Hansen, J
McDonald, G
Martin, PJ
Nichols, G
Radich, J
Woolfrey, A
Schleyer, E
Jenke, A
Thiede, C
Ehninger, G
Anasetti, C
机构
[1] Univ Hosp Carl Gustav Carus, Med Klin & Poliklin 1, Dresden, Germany
[2] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
799
引用
收藏
页码:213A / 213A
页数:1
相关论文
共 50 条
  • [11] Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia
    Lee, Seung-Shin
    Jung, Sung-Hoon
    Do, Young Rok
    Kim, Dae Sik
    Lee, Ji Hyun
    Park, Han-Seung
    Moon, Joon Ho
    Yi, Jun Ho
    Park, Yong
    Koh, Youngil
    Yhim, Ho-Young
    Choi, Yunsuk
    Mun, Yeung-Chul
    Lee, Won-Sik
    Lee, Seok
    Yang, Deok-Hwan
    YONSEI MEDICAL JOURNAL, 2020, 61 (06) : 452 - 459
  • [12] Role of thymoglobulin in matched sibling allogeneic hematopoietic stem cell transplantation with busulfan and fludarabine conditioning in myeloid malignanicies
    Shin, D-Y
    Lee, J-H
    Park, S.
    Lee, J-O
    Moon, J-H
    Ahn, J-S
    Choi, Y.
    Song, I-C
    Shin, H-J
    Lee, W. S.
    Lee, H. S.
    Yoon, S-S
    BONE MARROW TRANSPLANTATION, 2018, 53 (02) : 207 - 212
  • [13] Role of thymoglobulin in matched sibling allogeneic hematopoietic stem cell transplantation with busulfan and fludarabine conditioning in myeloid malignanicies
    D-Y Shin
    J-H Lee
    S Park
    J-O Lee
    J-H Moon
    J-S Ahn
    Y Choi
    I-C Song
    H-J Shin
    W S Lee
    H S Lee
    S-S Yoon
    Bone Marrow Transplantation, 2018, 53 : 207 - 212
  • [14] Prospective phase II study of allogeneic hematopoietic stem cell transplantation with targeted busulfan, fludarabine, and etoposide conditioning in pediatric acute lymphoblastic leukemia
    Hong, Kyung Taek
    Park, Hyun Jin
    Kim, Bo Kyung
    Choi, Jung Yoon
    Song, Sang Hoon
    Lee, Seunghwan
    Yu, Kyung-Sang
    Jang, In-Jin
    Kang, Hyoung Jin
    HEMASPHERE, 2024, 8 (12):
  • [15] CONDITIONING WITH NON-TARGETED BUSULFAN AND FLUDARABINE FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTATION: A STUDY OF ENGRAFTMENT KINETICS
    Nathan, S.
    Tuncer, H.
    Maciejewski, J.
    Venugopal, P.
    Larson, M.
    Shammo, J.
    Gregory, S.
    Fung, H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 112 - 112
  • [16] Fludarabine and Targeted Busulfan Is Safe and Effective Conditioning Before Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia in First Remission
    Kunter, Ghada M.
    Perkins, Janelle
    Perez, Lia
    Pidala, Joseph
    Field, Teresa
    Tomblyn, Marcie
    Fernandez, Hugo F.
    Anasetti, Claudio
    BLOOD, 2011, 118 (21) : 407 - 407
  • [17] Busulfan area-under-the-curve finding study within a busulfan/fludarabine (BuFlu) conditioning regimen before allogeneic hematopoietic cell Transplantation (HCT).
    Field, Teresa
    Perkins, Janelle
    Alsina, Melissa
    Ayala, Ernesto
    Fancher, Karen
    Fernandez, Hugo F.
    Garrett, Dawn
    Janssen, William
    Kharfan-Dabaja, Mohamed
    Perez, Lia
    Sullivan, Daniel
    Tate, Cheryl
    Anasetti, Claudio
    BLOOD, 2006, 108 (11) : 832A - 832A
  • [18] Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patients
    Dai, Zhiming
    Liu, Jie
    Zhang, Wang-Gang
    Cao, Xingmei
    Zhang, Yang
    Dai, Zhijun
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (04) : 667 - 671
  • [19] Impact of age on outcome after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning with Fludarabine/Busulfan
    Bethge, W. A.
    Federmann, B.
    Helwig, A.
    Faul, C.
    Vogel, W.
    Kanz, L.
    ONKOLOGIE, 2012, 35 : 129 - 129
  • [20] Allogeneic Hematopoietic Stem Cell Transplantation after Conditioning Regimens with Fludarabine/melphalan or Fludarabine/busulfan for Patients with Hematological Malignancies: A Single-center Analysis
    Yamamoto, Wataru
    Andou, Taiki
    Itabashi, Megumi
    Koyama, Satoshi
    Ishii, Yoshimi
    Numata, Ayumi
    Motohashi, Kenji
    Hagihara, Maki
    Matsumoto, Kenji
    Fujisawa, Shin
    INTERNAL MEDICINE, 2016, 55 (13) : 1721 - 1727